Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2019 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (184)	8/24/2019 8:39:54 PM
From: andre_ybio	1 Recommendation Recommended By DewDiligence_on_SI Read Replies (1) \| Respond to of 280

Bulba We should have a study what comes first in human development: 1. Losing sense of humor. Trump joked about 'been chosen' to protect american intellectual property, or winning election in year 3000 and year 4000, and some declare that he is undermining the pillars of democracy 2. Losing sense of perspective. The market is up 60% since the election year 2016, but now a few percent down is considered the end of the word. andre

To: BulbaMan who wrote (184)	8/30/2019 7:46:03 PM
From: BulbaMan	Read Replies (1) \| Respond to of 280

8/30/2019 Contest update The week began with the shocking and sad news of the death of FibroGen CEO, Thomas Neff. FGEN has been a perennial Contest portfolio top pick and I imagine is a real life holding for many of you, as it is for me. Neff was respected as a scientist and CEO but the reaction by investors to his death was somewhat macabre, with FGEN’s stock initially jumping $3. Investors, it seems, believed Neff’s death made a FGEN buyout at a premium more likely in the near future. Meanwhile, at Friday’s close, the Contest median was up 10.33% YTD (vs. up 9.34% a week ago), the Nasdaq Biotech Index (NBI) was up 6.28% YTD (vs. up 5.56% a week ago) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 11.54% YTD (vs. up 10.09% a week ago), while the Nasdaq Composite Index (NCI) was up 20.01% YTD (vs. up 16.83% YTD a week ago). BULBA’s portfolio remained in first place with a 94.20% YTD gain. ANDRE’s portfolio, up 54.16% YTD, and OHMS’ portfolio, up 50.26% YTD, continued to hold on to second and third place. At Friday's close, 26 of the 39 Contest portfolios were now in the green, while 20 were still beating the NBI and 19 were still beating the SPSIBI. The 167 Contest stock picks have an average YTD gain of 14.65% and, moving back into positive territory, a median YTD gain of 1.58%. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) Enjoy a safe & relaxing Labor Day weekend biotechies! Peace & good health, Bulba 8/30/19 Rank Name Profit/Loss 1 BULBA 94,199 2 ANDRE 54,159 3 OHMS 50,259 4 KMASTR 46,374 5 ARTHUR 39,458 6 HOOD 35,699 7 DEWO 33,675 8 BMAZ 30,611 9 LANCE 28,574 10 BIOCQR 25,661 Week's Top 5 Gainers Symbol 8/23/19 8/30/19 Wk.%chg. NTEC 0.460 0.722 56.98% DMAC 2.310 2.980 29.00% PRTA 6.890 8.410 22.06% CDTX 1.430 1.680 17.48% HEMA 14.050 16.450 17.08% Week's Worst 5 Losers Symbol 8/23/19 8/30/19 Wk.%chg. PTE 4.860 3.710 -23.66% TOCA 4.140 3.250 -21.50% PLX 0.248 0.207 -16.27% ABEO 1.830 1.540 -15.85% ADXS 0.402 0.340 -15.39%